Dilger R, et al
and Howard Weiss, Vice President, Federal Programs, America's Health Insurance Plans Staff from CMS's Center for Medicare (Linda Anders, Kathryn Coleman, Martha Hennessey, Wanda Pigatt-Canty, Erica Sontag, Scott Sturiale, Tim Roe, Nishamarie Sherry) and Medicare-Medicaid Coordination Office (Vanessa Duran, Paul Precht, Marla Rothouse) Jim Verdier, Senior Fellow, Mathematica Policy Research, Inc
No, it is currently not FDA-approved
Moreover, it can serve as a biomarker for diagnosis and prognosis, as well as a therapeutic target for HCC
When evaluating experimental data, including a control analogue like Cagrilintide ensures reliable benchmarking for mechanistic interpretation
5 391 : 2550501103